Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
ABT-492 is a potent, selective oral Factor Xa inhibitor developed for anticoagulation therapy. Its core synthetic process involves complex heterocyclic coupling to ensure high stereoselectivity. The compound is characterized by the molecular formula C26H25F2N7O3 and CAS number 1098776-55-2.
Application
- Pharmaceutical Manufacturing: Active Pharmaceutical Ingredient (API) production for novel oral anticoagulants.
- Clinical Research: Preclinical studies evaluating efficacy in preventing venous thromboembolism.
- Cardiovascular Therapy: Development of drugs targeting stroke prevention in atrial fibrillation patients.
Precautions
Strictly regulated as an investigational new drug; clinical use is limited to controlled trials. Requires storage under inert atmosphere at -20°C to maintain stability. Personnel must utilize appropriate PPE due to potential toxicity during handling.